oligonucleotides for HSV-1 (Kansai)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Nameoligonucleotides for HSV-1 (Kansai)
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionAntisense oligonucleotide inhibitors
TargetsUpdating
Therapy Area/IndicationsHerpes Simplex Virus Type 1 Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKansai Reseach Institute
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKansai Reseach Institute
Active IndicationsN/A
Inactive IndicationsHerpes Simplex Virus Type 1 Infections

Other Information

ATC CodeN/A
Related LinksN/A